Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Japanese group discovers novel microbial metabolite with antitumor and immunosuppressive effects

Jan. 22, 1999

Bayer claims camptothecin glycoconjugates for use in cancer

Jan. 22, 1999

Medeva launches Anthra's valrubicin in first market

Jan. 22, 1999

Antimetastatic bis-indoles described in patent literature

Jan. 21, 1999

PARP inhibitors potentiate cytotoxicity of alkylating agents, bleomycin and radiation

Jan. 20, 1999

New formulation may facilitate clinical development of antagonist G

Jan. 20, 1999

XK-469, an analogue of the herbicide Assure, in clinical testing as antitumor agent

Jan. 20, 1999

Potential new use for Anticort to be tested in Romania

Jan. 20, 1999

Cell Pathways explores SAANDs as new class of anticancer drugs; patent issues in U.S.

Jan. 19, 1999

Dose of O6-benzylguanine for use with BCNU in brain cancer patients determined

Jan. 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026